Finding 599571 (2022-002)

Significant Deficiency
Requirement
C
Questioned Costs
-
Year
2022
Accepted
2022-11-22

AI Summary

  • Core Issue: The Organization lacked proper documentation for payment terms, resulting in payments to vendors exceeding the typical 30-day limit.
  • Impacted Requirements: Payments made beyond 30 days violate the FAR guidelines for cost-reimbursement contracts.
  • Recommended Follow-Up: Review and update payment procedures to ensure compliance with reimbursement timelines.

Finding Text

Criteria: For cost-reimbursement contracts under the Federal Acquisition Regulations (FAR), 52.216-7(b)(1), with relation to supplies and services purchased for use on the contract, ?ordinary course of business? would be in accordance with the terms and conditions of a subcontract or invoice, and ordinarily within 30 days of the request to the federal government for reimbursement. Condition: The Organization did not have adequate documentation of extended payment terms in the ordinary course of business, and exceeded the typical 30 days. Effect: Subset of vendors were paid later than 30 days from the date of the request for reimbursement from the government. Cause: The Organization has been extending terms and conditions of payments of vendors beyond 30 days from the date of reimbursement request, as necessary for overall operations and its cash management needs. Questioned costs: None. Context: Of the sample of 60, nine of the selections were paid to the vendors more than 30 days from request for reimbursement. Of those nine, five were paid within 30 days of the receipt of the reimbursement from the government. Recommendation: The Organization should review its procedures, and update as necessary.

Categories

Cash Management Procurement, Suspension & Debarment

Other Findings in this Audit

  • 23122 2022-002
    Significant Deficiency
  • 23123 2022-002
    Significant Deficiency
  • 23124 2022-002
    Significant Deficiency
  • 23125 2022-002
    Significant Deficiency
  • 23126 2022-002
    Significant Deficiency
  • 23127 2022-002
    Significant Deficiency
  • 23128 2022-002
    Significant Deficiency
  • 23129 2022-002
    Significant Deficiency
  • 23130 2022-002
    Significant Deficiency
  • 23131 2022-002
    Significant Deficiency
  • 23132 2022-002
    Significant Deficiency
  • 23133 2022-002
    Significant Deficiency
  • 23134 2022-002
    Significant Deficiency
  • 23135 2022-002
    Significant Deficiency
  • 599564 2022-002
    Significant Deficiency
  • 599565 2022-002
    Significant Deficiency
  • 599566 2022-002
    Significant Deficiency
  • 599567 2022-002
    Significant Deficiency
  • 599568 2022-002
    Significant Deficiency
  • 599569 2022-002
    Significant Deficiency
  • 599570 2022-002
    Significant Deficiency
  • 599572 2022-002
    Significant Deficiency
  • 599573 2022-002
    Significant Deficiency
  • 599574 2022-002
    Significant Deficiency
  • 599575 2022-002
    Significant Deficiency
  • 599576 2022-002
    Significant Deficiency
  • 599577 2022-002
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
12.615 11186 Apex $9.80M
12.RD 11076 Hmt $8.72M
12.RD 11205 F0002-F0004-Option 1 $5.91M
12.RD 11222 Meta (act 3) $1.14M
12.RD 11221 Astra-Ist $809,856
12.RD 11210 Admire $599,730
12.RD 11231 Talons $443,735
12.614 Community Economic Adjustment Assistance for Advance Planning and Economic Diversification $415,232
12.RD 11196 Darpa M2t $380,863
11.020 Cluster Grants $302,382
11.307 Economic Adjustment Assistance $236,483
12.RD 11208 F0005-To4 $234,165
12.910 11122 Leap $195,327
12.RD 11207 Ist Meams $136,117
12.RD 1118afrl Ace-Em $44,101
12.RD 11238 Emss $18,098
12.RD 11062 Rast $8,406